Document is current
Any future updates will be listed below
-
Authors
Fu, Hsun-Yi
Liu, Yuan-Hung
Li, Shao-Jung
Chang, Heng-Chia
Liu, Chun-Chieh
Lee, Chi-Ming
Huang, Chunn-Yao
Hsu, Chin-Wang
Ko, Chow-In
Wang, Yi-Chih
Chang, Wei-Tien
Wang, Ta-Jung
Ong, Jiann-Ruey
Sun, Jen-Tang
Chen, Jer-Shen
Hsu, Chan-Yang
Jang, Shih-Jung
Chen, Yu-Long
Lin, Yih-Hsin
Chien, Chen-Yen
Kung, Yu-Chung
Wang, Tzong-Luen
Yu, Hao-Chun
Hsu, Chaun-Chih
Chao, Chun-Chien
Chen, Chih-Wei
Hsu, Chien-Yi
Hsu, Shih-Chang
Chang, Te-I.
Yeh, Jong-Shiuan
Tsai, Min-Shan
Wei, Ling-Yi
Chou, Heng-Wen
Wang, Chih-Hsien
Chang, Chin-Hao
Chen, Chi-Ling
Tu, Yong-Kwang
Lin, Jiunn-Lee
Chen, Yih-Sharng
-
Funding
Funding for this research was provided by:
Taiwan Brain Disease Foundation
National Taiwan University Hospital (W1 program)
- License Information
-
More Information
Article History
Received: 25 October 2025
Accepted: 14 January 2026
First Online: 3 February 2026
Declarations
:
: The trial was approved by the IRB of each participating hospital and that deferred consent will be obtained. The information and the approval number will be provided in written consent.
: A statement that deferred consent includes consent for publication of anonymized data. Since this is a protocol, there are no patient details.
: The authors declare no competing interests.
